Fascination About AZD3965
Use of sturdy CYP1A2 inhibitors ought to be discontinued right before initiating pirfenidone and prevented during treatment; if strong CYP1A2 inhibitors are the only real drug of preference, dosage reductions are proposedSupplemental monitoring and dosage adjustment could possibly be wanted in accordance with product labeling of CYP1A2 substrates.7